Development of conventional subunit vaccines for anaplasmosis and babesiosis

Tick-borne hemoparasitic diseases of cattle continue to impact the beef industry throughout a large portion of the world. A substantial amount of research is currently focused on development of improved vaccines. The two main approaches being followed are: (1) use of conventional inactivated or nati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Veterinary parasitology 1995-03, Vol.57 (1), p.255-266
Hauptverfasser: Montenegro-James, S., Johnson, W.C., Goff, W.L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 266
container_issue 1
container_start_page 255
container_title Veterinary parasitology
container_volume 57
creator Montenegro-James, S.
Johnson, W.C.
Goff, W.L.
description Tick-borne hemoparasitic diseases of cattle continue to impact the beef industry throughout a large portion of the world. A substantial amount of research is currently focused on development of improved vaccines. The two main approaches being followed are: (1) use of conventional inactivated or native protein subunit vaccines, and (2) development of recombinant DNA technology for expression of selected immunogens. Recombinant or synthetic peptide based vaccines hold promise owing to the exquisitely defined nature of the product. However, the development is long-term, and will require extensive testing and risk assessment before field trials can be considered. Until then, more conventional subunit immunogens may offer an attractive alternative, and can be defined immunologically better than before. This paper reviews progress in the development of improved vaccines for anaplasmosis and babesiosis with an emphasis on the characterization of culture-derived babesial exoantigens. Both in vitro and in vivo information is presented.
doi_str_mv 10.1016/0304-4017(94)03124-F
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77362784</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>030440179403124F</els_id><sourcerecordid>16803334</sourcerecordid><originalsourceid>FETCH-LOGICAL-c407t-a538fb52c32265e0d91608cb558cdeb47fb8175f7811ae6af026141912ca5ff83</originalsourceid><addsrcrecordid>eNqFkE1r3DAQhkVJ2G62_QMhBZ9Ke3AysiRLvhTKNpsEluTSnoUsj4KCbW0keyH_vnZ32WNzmhnej4GHkCsK1xRoeQMMeM6Bym8V_w6MFjzffCBLqiTLCyHgjCxPlo_kIqUXAOBQygVZSFFJqdSSbH_hHtuw67AfsuAyG_r9tPrQmzZLYz32fsj2xlrfY8pciJnpza41qQvJp-lostrUmPx8fiLnzrQJPx_nivzZ3P5e3-fbp7uH9c9tbjnIITeCKVeLwrKiKAVCU9ESlK2FULbBmktXKyqFk4pSg6VxUJSU04oW1gjnFFuRr4feXQyvI6ZBdz5ZbFvTYxiTlpKVhVT8XSMtFTDGZiM_GG0MKUV0ehd9Z-KbpqBn2npGqWeUuuL6H229mWJfjv1j3WFzCh3xTvrlQXcmaPMcfdKP20oAU7SaxB8HESdUe49RJ-uxt9j4iHbQTfD___4Xr8GWug</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16803334</pqid></control><display><type>article</type><title>Development of conventional subunit vaccines for anaplasmosis and babesiosis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Montenegro-James, S. ; Johnson, W.C. ; Goff, W.L.</creator><contributor>Buening, G ; Montenegro-James, S (eds)</contributor><creatorcontrib>Montenegro-James, S. ; Johnson, W.C. ; Goff, W.L. ; Buening, G ; Montenegro-James, S (eds)</creatorcontrib><description>Tick-borne hemoparasitic diseases of cattle continue to impact the beef industry throughout a large portion of the world. A substantial amount of research is currently focused on development of improved vaccines. The two main approaches being followed are: (1) use of conventional inactivated or native protein subunit vaccines, and (2) development of recombinant DNA technology for expression of selected immunogens. Recombinant or synthetic peptide based vaccines hold promise owing to the exquisitely defined nature of the product. However, the development is long-term, and will require extensive testing and risk assessment before field trials can be considered. Until then, more conventional subunit immunogens may offer an attractive alternative, and can be defined immunologically better than before. This paper reviews progress in the development of improved vaccines for anaplasmosis and babesiosis with an emphasis on the characterization of culture-derived babesial exoantigens. Both in vitro and in vivo information is presented.</description><identifier>ISSN: 0304-4017</identifier><identifier>EISSN: 1873-2550</identifier><identifier>DOI: 10.1016/0304-4017(94)03124-F</identifier><identifier>PMID: 7597788</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>ANAPLASMA ; Anaplasma spp ; Anaplasmosis - immunology ; Anaplasmosis - prevention &amp; control ; Animals ; Antigens, Bacterial - immunology ; Antigens, Protozoan - immunology ; BABESIA ; Babesia spp ; Babesiosis - immunology ; Babesiosis - prevention &amp; control ; Bacterial Vaccines ; BOVIN ; CATTLE ; GANADO BOVINO ; Macromolecular Substances ; Protozoan Vaccines ; Ticks ; VACCIN ; VACCINES ; Vaccines, Synthetic ; VACUNA</subject><ispartof>Veterinary parasitology, 1995-03, Vol.57 (1), p.255-266</ispartof><rights>1995</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c407t-a538fb52c32265e0d91608cb558cdeb47fb8175f7811ae6af026141912ca5ff83</citedby><cites>FETCH-LOGICAL-c407t-a538fb52c32265e0d91608cb558cdeb47fb8175f7811ae6af026141912ca5ff83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/030440179403124F$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7597788$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Buening, G</contributor><contributor>Montenegro-James, S (eds)</contributor><creatorcontrib>Montenegro-James, S.</creatorcontrib><creatorcontrib>Johnson, W.C.</creatorcontrib><creatorcontrib>Goff, W.L.</creatorcontrib><title>Development of conventional subunit vaccines for anaplasmosis and babesiosis</title><title>Veterinary parasitology</title><addtitle>Vet Parasitol</addtitle><description>Tick-borne hemoparasitic diseases of cattle continue to impact the beef industry throughout a large portion of the world. A substantial amount of research is currently focused on development of improved vaccines. The two main approaches being followed are: (1) use of conventional inactivated or native protein subunit vaccines, and (2) development of recombinant DNA technology for expression of selected immunogens. Recombinant or synthetic peptide based vaccines hold promise owing to the exquisitely defined nature of the product. However, the development is long-term, and will require extensive testing and risk assessment before field trials can be considered. Until then, more conventional subunit immunogens may offer an attractive alternative, and can be defined immunologically better than before. This paper reviews progress in the development of improved vaccines for anaplasmosis and babesiosis with an emphasis on the characterization of culture-derived babesial exoantigens. Both in vitro and in vivo information is presented.</description><subject>ANAPLASMA</subject><subject>Anaplasma spp</subject><subject>Anaplasmosis - immunology</subject><subject>Anaplasmosis - prevention &amp; control</subject><subject>Animals</subject><subject>Antigens, Bacterial - immunology</subject><subject>Antigens, Protozoan - immunology</subject><subject>BABESIA</subject><subject>Babesia spp</subject><subject>Babesiosis - immunology</subject><subject>Babesiosis - prevention &amp; control</subject><subject>Bacterial Vaccines</subject><subject>BOVIN</subject><subject>CATTLE</subject><subject>GANADO BOVINO</subject><subject>Macromolecular Substances</subject><subject>Protozoan Vaccines</subject><subject>Ticks</subject><subject>VACCIN</subject><subject>VACCINES</subject><subject>Vaccines, Synthetic</subject><subject>VACUNA</subject><issn>0304-4017</issn><issn>1873-2550</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1r3DAQhkVJ2G62_QMhBZ9Ke3AysiRLvhTKNpsEluTSnoUsj4KCbW0keyH_vnZ32WNzmhnej4GHkCsK1xRoeQMMeM6Bym8V_w6MFjzffCBLqiTLCyHgjCxPlo_kIqUXAOBQygVZSFFJqdSSbH_hHtuw67AfsuAyG_r9tPrQmzZLYz32fsj2xlrfY8pciJnpza41qQvJp-lostrUmPx8fiLnzrQJPx_nivzZ3P5e3-fbp7uH9c9tbjnIITeCKVeLwrKiKAVCU9ESlK2FULbBmktXKyqFk4pSg6VxUJSU04oW1gjnFFuRr4feXQyvI6ZBdz5ZbFvTYxiTlpKVhVT8XSMtFTDGZiM_GG0MKUV0ehd9Z-KbpqBn2npGqWeUuuL6H229mWJfjv1j3WFzCh3xTvrlQXcmaPMcfdKP20oAU7SaxB8HESdUe49RJ-uxt9j4iHbQTfD___4Xr8GWug</recordid><startdate>19950301</startdate><enddate>19950301</enddate><creator>Montenegro-James, S.</creator><creator>Johnson, W.C.</creator><creator>Goff, W.L.</creator><general>Elsevier B.V</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7T5</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19950301</creationdate><title>Development of conventional subunit vaccines for anaplasmosis and babesiosis</title><author>Montenegro-James, S. ; Johnson, W.C. ; Goff, W.L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c407t-a538fb52c32265e0d91608cb558cdeb47fb8175f7811ae6af026141912ca5ff83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>ANAPLASMA</topic><topic>Anaplasma spp</topic><topic>Anaplasmosis - immunology</topic><topic>Anaplasmosis - prevention &amp; control</topic><topic>Animals</topic><topic>Antigens, Bacterial - immunology</topic><topic>Antigens, Protozoan - immunology</topic><topic>BABESIA</topic><topic>Babesia spp</topic><topic>Babesiosis - immunology</topic><topic>Babesiosis - prevention &amp; control</topic><topic>Bacterial Vaccines</topic><topic>BOVIN</topic><topic>CATTLE</topic><topic>GANADO BOVINO</topic><topic>Macromolecular Substances</topic><topic>Protozoan Vaccines</topic><topic>Ticks</topic><topic>VACCIN</topic><topic>VACCINES</topic><topic>Vaccines, Synthetic</topic><topic>VACUNA</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Montenegro-James, S.</creatorcontrib><creatorcontrib>Johnson, W.C.</creatorcontrib><creatorcontrib>Goff, W.L.</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Veterinary parasitology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Montenegro-James, S.</au><au>Johnson, W.C.</au><au>Goff, W.L.</au><au>Buening, G</au><au>Montenegro-James, S (eds)</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of conventional subunit vaccines for anaplasmosis and babesiosis</atitle><jtitle>Veterinary parasitology</jtitle><addtitle>Vet Parasitol</addtitle><date>1995-03-01</date><risdate>1995</risdate><volume>57</volume><issue>1</issue><spage>255</spage><epage>266</epage><pages>255-266</pages><issn>0304-4017</issn><eissn>1873-2550</eissn><abstract>Tick-borne hemoparasitic diseases of cattle continue to impact the beef industry throughout a large portion of the world. A substantial amount of research is currently focused on development of improved vaccines. The two main approaches being followed are: (1) use of conventional inactivated or native protein subunit vaccines, and (2) development of recombinant DNA technology for expression of selected immunogens. Recombinant or synthetic peptide based vaccines hold promise owing to the exquisitely defined nature of the product. However, the development is long-term, and will require extensive testing and risk assessment before field trials can be considered. Until then, more conventional subunit immunogens may offer an attractive alternative, and can be defined immunologically better than before. This paper reviews progress in the development of improved vaccines for anaplasmosis and babesiosis with an emphasis on the characterization of culture-derived babesial exoantigens. Both in vitro and in vivo information is presented.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>7597788</pmid><doi>10.1016/0304-4017(94)03124-F</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0304-4017
ispartof Veterinary parasitology, 1995-03, Vol.57 (1), p.255-266
issn 0304-4017
1873-2550
language eng
recordid cdi_proquest_miscellaneous_77362784
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects ANAPLASMA
Anaplasma spp
Anaplasmosis - immunology
Anaplasmosis - prevention & control
Animals
Antigens, Bacterial - immunology
Antigens, Protozoan - immunology
BABESIA
Babesia spp
Babesiosis - immunology
Babesiosis - prevention & control
Bacterial Vaccines
BOVIN
CATTLE
GANADO BOVINO
Macromolecular Substances
Protozoan Vaccines
Ticks
VACCIN
VACCINES
Vaccines, Synthetic
VACUNA
title Development of conventional subunit vaccines for anaplasmosis and babesiosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T20%3A03%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20conventional%20subunit%20vaccines%20for%20anaplasmosis%20and%20babesiosis&rft.jtitle=Veterinary%20parasitology&rft.au=Montenegro-James,%20S.&rft.date=1995-03-01&rft.volume=57&rft.issue=1&rft.spage=255&rft.epage=266&rft.pages=255-266&rft.issn=0304-4017&rft.eissn=1873-2550&rft_id=info:doi/10.1016/0304-4017(94)03124-F&rft_dat=%3Cproquest_cross%3E16803334%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16803334&rft_id=info:pmid/7597788&rft_els_id=030440179403124F&rfr_iscdi=true